Advocates: Engagement With Patients Key To Long-Term Registry Participation

By Jessica Karins / May 14, 2024 at 5:14 PM
Regular engagement with patients participating in registries is key to ensuring they continue to participate in long-term follow-up about a disease’s progression or the effectiveness of a treatment, leaders of patient advocate groups who have created effective registries said this week. The advice comes as FDA officials struggle with how to keep patients in registries and are looking at possible incentives. The topic was discussed at a workshop hosted by FDA and the Reagan-Udall Foundation Monday (May 13) that focused...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.